ZyVersa Therapeutics, Inc.
ZVSA· OTC
ZVSAZyVersa Therapeutics, Inc.
Filed Nov 14, 2023 · 10-Q · 45 days after period end · 0001493152-23-041185
| Metric | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|
| Net Income | -$2.90M | -$679.09K | -$174.00 |
| EPS Diluted | -$30.18 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ZyVersa Therapeutics, Inc. · CIK 1859007 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 14, 2023 · 45 d after period end
